ImmunityBio Dividend
Dividend criteria checks 0/6
ImmunityBio does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 2.9% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$0.86 |
Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
ImmunityBio Lights Up: Anktiva's FDA Nod Shakes Up Bladder Cancer Battle
Apr 23ImmunityBio: Financial And Regulatory Risks Outweigh Anktiva's Promise
Feb 27ImmunityBio: Buy Low Now Vs. Buy High Later
Feb 11ImmunityBio: PDUFA Pending
Oct 17ImmunityBio: Compelling Data In Bladder Cancer, Yet Funding Issues Remain
Aug 07ImmunityBio: Ready To Shift Gears After Long-Awaited BLA Submission
Jun 02ImmunityBio: Extensive Pipeline, NDA Expected For Anktiva This Quarter
Mar 15ImmunityBio: Company Leaves 2021 On A High-Note; Share Price Still Falls Flat
Dec 27ImmunityBio: Demoralization Of The Bulls By Deflating The Share Price
Oct 12ImmunityBio: Market Has Lost Contact Following Merger
Jul 19ImmunityBio posts results from early-stage blood cancer study
May 04Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if IBRX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if IBRX's dividend payments have been increasing.
Dividend Yield vs Market
ImmunityBio Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (IBRX) | n/a |
Market Bottom 25% (US) | 1.6% |
Market Top 25% (US) | 4.8% |
Industry Average (Biotechs) | 2.9% |
Analyst forecast in 3 Years (IBRX) | n/a |
Notable Dividend: Unable to evaluate IBRX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate IBRX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate IBRX's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as IBRX has not reported any payouts.